At a glance
The March 30, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on serology testing, emergency use authorizations, CLIA guidance, surveillance, and biosafety.
Agenda
Welcome and Introductions: Jasmine Chaitram, CDC Division of Laboratory Systems
Serology Testing, Updated Testing Guidance, Nasal Swabs: Wendi Kuhnert-Tallman, CDC Laboratory Task Force
Emergency Use Authorizations (EUAs) for Serology Tests and At-Home/Self-Collection Tests: Tim Stenzel, U.S. Food and Drug Administration (FDA)
New CLIA Guidance and Validating Tests for Laboratories Responding to COVID-19: Karen Dyer, Centers for Medicare & Medicaid Services (CMS)
Supporting Epidemiologic and Surveillance Needs: Janet Hamilton, Council of State and Territorial Epidemiologists (CSTE)
Laboratory Biosafety Update: Bill Arndt, CDC Division of Laboratory Systems